Fan B, Wang M. Ruxolitinib, a JAK1/2 Inhibitor as Treatment for Paraneoplastic Pemphigus: A Case Report. Acta Derm Venereol [Internet]. 2022 Jun. 9 [cited 2024 Sep. 22];102:adv00732. Available from: https://medicaljournalssweden.se/actadv/article/view/1378